|
51 |
Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial Enthalten in Trials Bd. 13, 26.10.2012, Nr. 1, date:12.2012: 1-9
|
|